Evaluation of global progress towards HBV and HCV elimination
Sarah Blach(Center for Disease Analysis), Homie Razavi(Center for Disease Analysis), Ellen Mooneyhan(Center for Disease Analysis), Chris Estes(Center for Disease Analysis), Kathryn Razavi‐Shearer(Center for Disease Analysis), Devin Razavi‐Shearer(University of Health Sciences Antigua), Ivane Gamkrelidze
Cited by 9
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399